Dr. Pandit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Baylor Plz
# Jones
Houston, TX 77030Phone+1 713-798-2400
Education & Training
- Baylor College of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2008
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2000 - 2003
- University of Texas Southwestern Medical SchoolClass of 2000
Certifications & Licensure
- TX State Medical License 2008 - 2025
- IA State Medical License 2000 - 2004
Publications & Presentations
PubMed
- Treatment of Severe COVID-19 Infection With Remdesivir in Peritoneal Dialysis.Ryan Geffin, Shazia Raheem, Lavannya M Pandit, Andrew S Hunter, Michael W Holliday Jr
Journal of Investigative Medicine High Impact Case Reports. 2023-09-21 - 3 citationsAssociation of Glucose-6-Phosphate Dehydrogenase Deficiency With Outcomes in US Veterans With COVID-19.Sarah H Elsea, Javad Razjouyan, Kyung Min Lee, Julie A Lynch, Sharyl Martini
JAMA Network Open. 2023-03-01 - 29 citationsThe Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19., Angela J Rogers, Deborah Wentworth, Andrew Phillips, Katy Shaw-Saliba
Annals of Internal Medicine. 2022-10-01
Journal Articles
- Tocilizumab in Patients Hospitalized with Covid-19 PneumoniaGerard J Criner, Lavannya Pandit, The New England Journal of Medicine
Press Mentions
- Common Enzyme Deficiency Linked with COVID SeverityMarch 29th, 2023
- Why Science Shouldn’t Be ‘Colorblind’June 18th, 2021
- Trial Results Show Potential Benefits of Tocilizumab for COVID-19February 25th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: